Literature DB >> 11058077

ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis.

J D Norton1.   

Abstract

The ubiquitously expressed family of ID helix-loop-helix (HLH) proteins function as dominant negative regulators of basic HLH (bHLH) transcriptional regulators that drive cell lineage commitment and differentiation in metazoa. Recent data from cell line and in vivo studies have implicated the functions of ID proteins in other cellular processes besides negative regulation of cell differentiation. ID proteins play key roles in the regulation of lineage commitment, cell fate decisions and in the timing of differentiation during neurogenesis, lymphopoiesis and neovascularisation (angiogenesis). They are essential for embryogenesis and for cell cycle progression, and they function as positive regulators of cell proliferation. ID proteins also possess pro-apoptotic properties in a variety of cell types and function as cooperating or dominant oncoproteins in immortalisation of rodent and human cells and in tumour induction in Id-transgenic mice. In several human tumour types, the expression of ID proteins is deregulated, and loss- and gain-of-function studies implicate ID functions in the regulation of tumour growth, vascularisation, invasiveness and metastasis. More recent biochemical studies have also revealed an emerging 'molecular promiscuity' of mammalian ID proteins: they directly interact with and modulate the activities of several other families of transcriptional regulator, besides bHLH proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058077     DOI: 10.1242/jcs.113.22.3897

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  219 in total

1.  Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.

Authors:  E C Roberts; R W Deed; T Inoue; J D Norton; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  A novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesion.

Authors:  John J Murphy; Paul Hobby; Juan Vilarino-Varela; Benjamin Bishop; Panagiota Iordanidou; Brian J Sutton; John D Norton
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 3.  Transcriptional regulation of hepatic stellate cell activation.

Authors:  D A Mann; D E Smart
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 4.  Inhibitors of DNA binding in neural cell proliferation and differentiation.

Authors:  Shun-Fen Tzeng
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

5.  Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion.

Authors:  Alexis Cutchins; Daniel B Harmon; Jennifer L Kirby; Amanda C Doran; Stephanie N Oldham; Marcus Skaflen; Alexander L Klibanov; Nahum Meller; Susanna R Keller; James Garmey; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-10       Impact factor: 8.311

Review 6.  Helix-loop-helix proteins in mammary gland development and breast cancer.

Authors:  Pierre-Yves Desprez; Tomoki Sumida; Jean-Philippe Coppé
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

7.  BMP-2 decreases Mash1 stability by increasing Id1 expression.

Authors:  Francesc Viñals; Julia Reiriz; Santiago Ambrosio; Ramon Bartrons; Jose Luis Rosa; Francesc Ventura
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

8.  Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development.

Authors:  Huajie Li; Ming Ji; Kimberly D Klarmann; Jonathan R Keller
Journal:  Blood       Date:  2010-05-07       Impact factor: 22.113

9.  MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling.

Authors:  Basak Icli; A K M Wara; Javid Moslehi; Xinghui Sun; Eva Plovie; Meghan Cahill; Julio F Marchini; Andrew Schissler; Robert F Padera; Jianru Shi; Hui-Wen Cheng; Srilatha Raghuram; Zoltan Arany; Ronglih Liao; Kevin Croce; Calum MacRae; Mark W Feinberg
Journal:  Circ Res       Date:  2013-09-18       Impact factor: 17.367

10.  Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.

Authors:  Binwu Tang; Naomi Yoo; Mary Vu; Mizuko Mamura; Jeong-Seok Nam; Akira Ooshima; Zhijun Du; Pierre-Yves Desprez; Miriam R Anver; Aleksandra M Michalowska; Joanna Shih; W Tony Parks; Lalage M Wakefield
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.